deltatrials
Terminated NCT00962234

Metabolism of Lipids in Advanced Cancer

Sponsor: AHS Cancer Control Alberta

Conditions Cachexia Lung Neoplasms
Interventions Blood draws Metabolic rate testing Oral administration of stable isotope (deuterium)
Updated 10 times since 2017 Last updated: Feb 24, 2016 Started: Oct 31, 2009 Primary completion: Oct 31, 2011 Completion: Oct 31, 2011

Listed as NCT00962234, this observational or N/A phase trial focuses on Cachexia and Lung Neoplasms and remains terminated or withdrawn. Sponsored by AHS Cancer Control Alberta, it has been updated 10 times since 2009, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated

  4. Jan 2021 — Dec 2021 [monthly]

    Terminated

  5. Nov 2020 — Jan 2021 [monthly]

    Terminated

▶ Show 5 earlier versions

  1. Jun 2018 — Nov 2020 [monthly]

    Terminated

  2. May 2018 — Jun 2018 [monthly]

    Terminated

  3. Apr 2018 — May 2018 [monthly]

    Terminated

    Phase: NA → None

  4. Aug 2017 — Apr 2018 [monthly]

    Terminated NA

  5. Jan 2017 — Aug 2017 [monthly]

    Terminated NA

    First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AHS Cancer Control Alberta
  • Cross Cancer Institute
Data source: AHS Cancer Control Alberta

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Edmonton, Canada